Chemoradioimmunotherapy versus chemoimmunotherapy or chemoradiotherapy in extensive‐stage small‐cell lung cancer: A retrospective analysis of survival outcomes

Abstract Background and purpose Current evidence is insufficient to define the value of thoracic radiotherapy (TRT) following chemoimmunotherapy (CT‐IO) in extensive‐stage small‐cell lung cancer (ES‐SCLC). We aimed to ascertain whether incorporating immunotherapy (IO) could improve survival and expl...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jinmin Han, Ying Hua, Xue Wu, Xiufeng Tang, Chengxin Liu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2025-12-01
coleção:	Precision Radiation Oncology
Assuntos:	chemoimmunotherapy chemoradioimmunotherapy chemoradiotherapy extensive‐stage small cell lung cancer
Acesso em linha:	https://doi.org/10.1002/pro6.70043
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!